Diabetes

October 10, 2017

Natural product therapy for TIIDM and Metabolic defects: Yangonin, isolated from herb Kava kava/Piper methysticum, increases Sirtuin-4 expression, augments insulin secretion, reduces metabolic stress, improves glucose uptake, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 11/October/2017, 12.57 am

Introduction: What they say A study from the “Duke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, NC […]
October 10, 2017

Natural product therapy for body weight control, energy homeostasis and TIIDM:  A therapeutic mix [CNDGA]  encompassing Chlorogenic acid and  Nordihydroguaiaretic acid (NDGA)  decreases CADM1 and its downstream target genes that promote glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM via up regulation of its target gene, 11/October/2017, 12.38 am

Introduction: What they say A study from the Max Delbrück Center for Molecular Medicine, Berlin, Germany shows that “Regulation of body weight and energy homeostasis by […]
October 8, 2017

Natural product-based therapy for TIIDM and obesity-associated metabolic deficits: Yangonin, isolated from Kava Kava, increases Lipocalin 2 (LCN2) expression, activates an MC4R-dependent anorexigenic pathway, suppresses appetite and weight gain, increases insulin secretion, improves glucose tolerance, promotes glucose homeostasis, improves obesity-associated metabolic deficits and prevents progression to TIIDM via down regulation of its target gene, 9/October/2017, 1.18 am

Introduction: What they say A study from the Department of Physiology-Cellular Biophysics, College of Physicians and Surgeons, Columbia University, New York, New York, USA shows that […]
October 8, 2017

Natural product-based therapy for Metabolic diseases: Kavin, isolated from Kava Kava/Piper Methysticum, increases the expression of Caveolin-1, stabilizes insulin receptor, promotes insulin sensitivity, incrases vasorelaxation, and decreases the risk of hyperglycemia and TIIDM via up regulation of its target gene.., 09/October/2017, 1.11 am

Introduction: What they say A study from the Institute for Molecular Systems Biology, ETH Zurich, Zurich, Switzerland shows that “MicroRNAs 103 and 107 regulate insulin sensitivity.” This study was published, in the June […]